Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

From Meta to Microsoft, generative AI is accelerating Big Tech's salary divide.

OpenAI co-founder Ilya Sutskever has been named CEO of his artificial intelligence startup Safe Superintelligence. His ...

DeepMind's new AI system gives robots an inner voice, enabling zero-shot learning and efficient task mastery without prior ...

Meta Platforms has quietly assembled a powerhouse of Chinese AI researchers to staff its newly announced Meta ...

Google's Veo 3 AI video generator is now available globally for AI Pro subscribers, a key move in its revamped two-tier ...

There's little unexpected about this, especially as Genie 2, an AI model capable of generating interactive 3D environments, ...